索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]徐梦丹,戴秋艳.炎症与肥胖相关性高血压研究进展[J].国际心血管病杂志,2015,06:372-375.
点击复制

炎症与肥胖相关性高血压研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2015年06期
页码:
372-375
栏目:
综述
出版日期:
2015-11-25

文章信息/Info

Title:
-
作者:
徐梦丹; 戴秋艳
200086 上海交通大学附属第一人民医院心内科
Author(s):
-
关键词:
炎症; 肥胖; 高血压
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2015.06.002
文献标识码:
-
摘要:
炎症反应在肥胖相关性高血压的病理生理学机制中发挥重要作用。(1)脂肪组织是炎症反应的重要器官,其分泌各种脂肪细胞因子作为促炎症介质,后者对肥胖相关性高血压的发生具有促进或抑制作用。巨噬细胞和淋巴细胞在脂肪组织的浸润和激活促进了炎症反应的发生。(2)脂肪组织局部或全身循环中肾素-血管紧张素-醛固酮系统(RAAS)的激活,促进血压升高。(3)炎症反应引起胰岛素介导的血管收缩和舒张功能平衡失调,导致微血管功能障碍。
Abstract:
-

参考文献/References

[1] Kang YS.Obesity associated hypertension: new insights into mechanism[J].Electrolyte Blood Press,2013,11(2):46-52.
[2] Badimon L, Romero JC, Cubedo J,et al.Circulating biomarkers[J].Thromb Res,2012,130 Suppl 1:S12-S15.
[3] Badimon L.Interleukin-18: a potent pro-inflammatory cytokine in atherosclerosis[J].Cardiovasc Res,2012,96(2):172-175; discussion 176-180.
[4] Ishii M, Wen H, Corsa CA,et al.Epigenetic regulation of the alternatively activated macrophage phenotype[J].Blood,2009,114(15):3244-3254.
[5] Esser N, Legrand-Poels S, Piette J,et al.Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J].Diabetes Res Clin Pract,2014,105(2):141-150.
[6] Ghigliotti G, Barisione C, Garibaldi S,et al.Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions[J].Inflammation,2014,37(4):1337-1353.
[7] Ohmura K, Ishimori N, Ohmura Y,et al.Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice[J].Arterioscler Thromb Vasc Biol,2010,30(2):193-199.
[8] Hotamisligil GS, Shargill NS, Spiegelman BM.Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance[J].Science,1993,259(5091):87-91.
[9] Lorenzo M, Fernández-Veledo S, Vila-Bedmar R,et al.Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes[J].J Anim Sci,2008,86(14 Suppl):E94-E104.
[10] Solomon SS, Odunusi O, Carrigan D,et al.TNF-alpha inhibits insulin action in liver and adipose tissue: A model of metabolic syndrome[J].Horm Metab Res,2010,42(2):115-121.
[11] Hivert MF, Sullivan LM, Shrader P,et al.The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans[J].Metabolism,2010,59(4):540-546.
[12] Lee S, Kwak HB.Role of adiponectin in metabolic and cardiovascular disease[J].J Exerc Rehabil,2014,10(2):54-59.
[13] Fu Y.Adiponectin signaling and metabolic syndrome[J].Prog Mol Biol Transl Sci,2014,121:293-319.
[14] Tsioufis C, Dimitriadis K, Selima M,et al.Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients[J].Eur Heart J,2007,28(9):1162-1169.
[15] Hui E, Xu A, Chow WS,et al.Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study[J].Metab Syndr Relat Disord,2014,12(10):517-522.
[16] Go O, Freeman RH, Reams GP,et al.Obesity hypertension: pathophysiological role of leptin in neuroendocrine dysregulation[J].Am J Med Sci,2014,347(6):485-489.
[17] Tsuda K.Role of hyperleptinemia in the regulation of blood pressure and cardiac function[J].Hypertension,2014,63(1):e1.
[18] Taylor PD, Samuelsson AM, Poston L.Maternal obesity and the developmental programming of hypertension: a role for leptin[J].Acta Physiol(Oxf),2014,210(3):508-523.
[19] Momin AU, Melikian N, Shah AM,et al.Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance[J].Eur Heart J,2006,27(19):2294-2299.
[20] Leung YM, Kwan CY.Dual vascular effects of leptin via endothelium: hypothesis and perspective[J].Chin J Physiol,2008,51(1):1-6.
[21] Weikert C, Westphal S, Berger K,et al.Plasma resistin levels and risk of myocardial infarction and ischemic stroke[J].J Clin Endocrinol Metab,2008,93(7):2647-2653.
[22] Barnes KM, Miner JL.Role of resistin in insulin sensitivity in rodents and humans[J].Curr Protein Pept Sci,2009,10(1):96-107.
[23] Park HK, Ahima RS.Resistin in rodents and humans[J].Diabetes Metab J,2013,37(6):404-414.
[24] Tatemoto K, Hosoya M, Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophys Res Commun,1998,251(2):471-476.
[25] Japp AG, Cruden NL, Barnes G,et al.Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure[J].Circulation,2010,121(16):1818-1827.
[26] Wu H, Cheng XW, Hao C,et al.Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes[J].Exp Anim,2014,63(2):257-267.
[27] Schäffler A, Schölmerich J.Innate immunity and adipose tissue biology[J].Trends Immunol,2010,31(6):228-235.
[28] Nishimura S, Manabe I, Nagasaki M,et al.CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity[J].Nat Med,2009,15(8):914-920.
[29] Harford KA, Reynolds CM, McGillicuddy FC,et al.Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue[J].Proc Nutr Soc,2011,70(4):408-417.
[30] Frigolet ME, Torres N, Tovar AR.The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity[J].J Nutr Biochem,2013,24(12):2003-2015.
[31] Lastra G, Sowers JR.Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system[J].Horm Mol Biol Clin Investig,2013,15(2):49-57.
[32] Kim JA, Montagnani M, Koh KK,et al.Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms[J].Circulation,2006,113(15):1888-1904.
[33] Campia U, Tesauro M, Cardillo C.Human obesity and endothelium-dependent responsiveness[J].Br J Pharmacol,2012,165(3):561-573.
[34] Hickner RC, Kemeny G, Stallings HW,et al.Relationship between body composition and skeletal muscle eNOS[J].Int J Obes(Lond),2006,30(2):308-312.
[35] 芦 波,桂明泰,符德玉.肥胖相关高血压的发病机制[J].国际心血管病杂志,2015,42(1):16-25.

备注/Memo

备注/Memo:
通信作者:戴秋艳,Email:daiqiuyan@medmail.com.cn
更新日期/Last Update: 2015-12-20